Characteristics | All participants (N=319,568) | Without digestive system cancers (N=312,652) | Digestive system cancersa (N=6916) | Ptrend |
---|---|---|---|---|
HDL-C (mmol/L) | 1.409 [1.181;1.685] | 1.410 [1.182;1.686] | 1.358 [1.135;1.635] | <0.001 |
LDL-C (mmol/L) | 3.536 [2.965;4.135] | 3.536 [2.967;4.136] | 3.508 [2.888;4.111] | <0.001 |
TG (mmol/L) | 1.481 [1.046;2.138] | 1.478 [1.044;2.134] | 1.621 [1.140;2.321] | <0.001 |
Age (years) | 58 [50;63] | 58 [50;63] | 62 [58;66] | 0.000 |
Sex, n (%) | Â | Â | Â | <0.001 |
 Female | 173,073 (54.158%) | 170,089 (54.402%) | 2984 (43.146%) |  |
 Male | 146495 (45.842%) | 142563 (45.598%) | 3932 (56.854%) |  |
BMI (kg/m2) | 26.655 [24.089;29.750] | 26.638 [24.076;29.728] | 27.367 [24.794;30.504] | <0.001 |
Smoking status, n (%) | Â | Â | Â | <0.001 |
 Never | 173,465 (54.281%) | 170,425 (54.509%) | 3040 (43.956%) |  |
 Previous | 113,615 (35.553%) | 110,571 (35.366%) | 3044 (44.014%) |  |
 Current | 32,488 (10.166%) | 31,656 (10.125%) | 832 (12.030%) |  |
Alcohol drinking status, n (%) | Â | Â | Â | 0.002 |
 Never | 10,036 (3.140%) | 9801 (3.135%) | 235 (3.398%) |  |
 Previous | 10,494 (3.284%) | 10,219 (3.268%) | 275 (3.976%) |  |
 Current | 299,038 (93.576%) | 292,632 (93.597%) | 6406 (92.626%) |  |
Education qualification, n (%) | Â | Â | Â | 0.262 |
 None | 55,338 (17.317%) | 54,142 (17.317%) | 1196 (17.293%) |  |
 NVQ/CSE/O/A levels | 143,063 (44.768%) | 140,027 (44.787%) | 3036 (43.898%) |  |
 Professional/college or university degree | 121,167 (37.916%) | 118,483 (37.896%) | 2684 (38.809%) |  |
Employment status, n (%) | Â | Â | Â | <0.001 |
 None employed | 134,924 (42.221%) | 130,912 (41.871%) | 4012 (58.010%) |  |
 Current employed | 184,644 (57.779%) | 181,740 (58.129%) | 2904 (41.990%) |  |
Medication useb, n (%) | Â | Â | Â | <0.001 |
 None | 219,136 (68.573%) | 214,976 (68.759%) | 4160 (60.150%) |  |
 Yes | 100,432 (31.427%) | 97,676 (31.241%) | 2756 (39.850%) |  |
TDI | -2.305 [-3.710;0.134] | -2.305 [-3.711;0.131] | -2.283 [-3.669;0.348] | 0.023 |
Physical activity level, n (%) | Â | Â | Â | 0.066 |
 None | 18,014 (5.637%) | 17,580 (5.623%) | 434 (6.275%) |  |
 Light/Moderate activity | 252,040 (78.869%) | 246,619 (78.880%) | 5421 (78.383%) |  |
 Heavy/Strenuous activity | 49,514 (15.494%) | 48,453 (15.497%) | 1061 (15.341%) |  |
Family cancer history, n (%) | Â | Â | Â | <0.001 |
 None | 219,398 (68.655%) | 214,870 (68.725%) | 4528 (65.471%) |  |
 Yes | 100,170 (31.345%) | 97,782 (31.275%) | 2388 (34.529%) |  |
Fasting time (hours) | 4 [4;5] | 4 [4;5] | 4 [4;5] | 1.000 |
ALT (U/L) | 24.300 [21.000;28.600] | 24.300 [21.000;28.600] | 24.900 [21.400;29.200] | <0.001 |
AST (U/L) | 20.000 [15.340;27.090] | 19.990 [15.330;27.070] | 20.740 [15.818;27.490] | <0.001 |
SBP (mmHg) | 138 [126;152] | 138 [126;152] | 143 [130;156] | <0.001 |
DBP (mmHg) | 82 [75;89] | 82 [75;89] | 83 [76;90] | <0.001 |
Cerebral infarction, n (%) | Â | Â | Â | <0.001 |
 None | 312,384 (97.752%) | 305,740 (97.789%) | 6644 (96.067%) |  |
 Yes | 7184 (2.248%) | 6912 (2.211%) | 272 (3.933%) |  |
Ischaemic heart disease, n (%) | Â | Â | Â | <0.001 |
 None | 289,703 (90.655%) | 283,787 (90.768%) | 5916 (85.541%) |  |
 Yes | 29,865 (9.345%) | 28,865 (9.232%) | 1000 (14.459%) |  |
Primary hypertension, n (%) | Â | Â | Â | <0.001 |
 None | 226,576 (70.901%) | 222,979 (71.319%) | 3597 (52.010%) |  |
 Yes | 92,992 (29.099%) | 89,673 (28.681%) | 3319 (47.990%) |  |
HbA1c (mmol/mol) | 35.100 [32.700;37.700] | 35.100 [32.700;37.600] | 36.050 [33.500;38.800] | <0.001 |
Diabetes, n (%) | Â | Â | Â | <0.001 |
 None | 296,342 (92.732%) | 29,0557 (92.933%) | 5785 (83.647%) |  |
 Yes | 23,226 (7.268%) | 22,095 (7.067%) | 1131 (16.353%) |  |